Immediate Impact
59 standout
Citing Papers
Acute lymphoblastic leukaemia
2024 Standout
Management of ALL in adults: 2024 ELN recommendations from a European expert panel
2024 Standout
Works of Samuel Dara being referenced
First report of phase 2 study of dasatinib with hyper-CVAD for the frontline treatment of patients with Philadelphia chromosome–positive (Ph+) acute lymphoblastic leukemia
2010
Phase II Study of Combination of the Hypercvad Regimen with Dasatinib in the Front Line Therapy of Patients with Philadelphia Chromosome (Ph) Positive Acute Lymphoblastic Leukemia (ALL).
2009
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Samuel Dara | 251 | 73 | 251 | 10 | 307 | |
| R. Rutledge | 206 | 34 | 263 | 12 | 334 | |
| Ku S | 216 | 116 | 114 | 8 | 312 | |
| Henrik Schr�der | 149 | 46 | 232 | 13 | 369 | |
| M.A. Piñán | 94 | 32 | 170 | 8 | 308 | |
| Jodie E. Giles | 163 | 38 | 217 | 10 | 314 | |
| Stacey Richardson | 161 | 68 | 185 | 10 | 310 | |
| K Miyamura | 318 | 72 | 107 | 15 | 353 | |
| H-J Kolb | 273 | 59 | 124 | 9 | 311 | |
| A Chauvenet | 230 | 39 | 226 | 9 | 312 | |
| D. Snyder | 299 | 99 | 100 | 10 | 347 |
All Works
Loading papers...